Newron Pharmaceuticals
NWRN.SW
#8413
Rank
NZ$0.53 B
Marketcap
NZ$25.56
Share price
-1.30%
Change (1 day)
36.94%
Change (1 year)

Half-year Reports

Thumbnail Newron Pharmaceuticals Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2017-h1

Half-year Report 2017-h1

Language: English

View Half-year Report